TANG CAPITAL PARTNERS LP 13D and 13G filings for La Jolla Pharmaceutical Company:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-08-24 4:00 pm Sale | 2022-08-22 | 13D | La Jolla Pharmaceutical Company LJPC | TANG CAPITAL PARTNERS LP | 0 0.000% | -9,959,934 (Position Closed) | Filing |
2022-07-11 6:15 pm Unchanged | 2022-07-10 | 13D | La Jolla Pharmaceutical Company LJPC | TANG CAPITAL PARTNERS LP | 9,959,934 39.800% | 0 (Unchanged) | Filing |
2021-12-02 08:30 am Sale | 2021-12-01 | 13D | La Jolla Pharmaceutical Company LJPC | TANG CAPITAL PARTNERS LP | 9,959,934 36.000% | -166,270 (-1.64%) | Filing |
2021-05-27 06:03 am Purchase | 2021-05-26 | 13D | La Jolla Pharmaceutical Company LJPC | TANG CAPITAL PARTNERS LP | 10,126,204 36.800% | 410,714 (+4.23%) | Filing |
2020-09-11 06:02 am Purchase | 2020-09-09 | 13D | La Jolla Pharmaceutical Company LJPC | TANG CAPITAL PARTNERS LP | 9,715,490 35.400% | 278,369 (+2.95%) | Filing |
2020-08-18 06:05 am Purchase | 2020-08-14 | 13D | La Jolla Pharmaceutical Company LJPC | TANG CAPITAL PARTNERS LP | 9,437,121 34.400% | 431,647 (+4.79%) | Filing |
2020-06-05 06:04 am Purchase | 2020-06-02 | 13D | La Jolla Pharmaceutical Company LJPC | TANG CAPITAL PARTNERS LP | 9,005,474 32.900% | 784,899 (+9.55%) | Filing |